Excelsior Correspondent
JAMMU, May 9: As a part of Apollo’s initiative of providing advanced treatment to people across the country, Indraprastha Apollo Hospitals organized an awareness event around the rising cases of Thalassemia patients across India and the advanced media treatment available that provides cure for all.
The initiative was led by P Shivakumar (Managing Director, Indraprastha Apollo Hospitals), Dr Gaurav Kharya (Advisor, Bone Marrow Transplant and Cellular Therapy), Dr Amita Mahajan (Senior Consultant, Paediatrics Oncology and Hematology) and Dr Shanthi Bansal (Director Medical Services).
The program focused on the signs and symptoms, treatment modalities, and diagnostic tests to promote treatment for Thalassemia. Over the past year, Indraprastha Apollo Hospital has witnessed some challenging cases of Thalassemia and provided treatment via the advanced medical facilities available at the hospital.
Addressing the Program, Dr Gaurav Kharya said, “Thalassemia major is a preventable illness, thus more efforts and awareness is required to help people understand the ways of preventing Thalassemia. Having said this there are a large number of kids who continue to suffer from Thalassemia with huge psychological and financial burden leading to poor quality of life and decreased life expectancy. Just like being preventable, for kids affected with Thalassemia major, it is very much a curable disease by offering a bone marrow transplant using either HLA identical or haploidentical donor.
Dr Amita Mahajan added, “When we discuss Thalassemia, we know that people are not only very fearful, but also there are a lot of misconceptions regarding its treatment. While we have observed major advances in the management of Thalassemia, however, myths and misconceptions regarding treatment and regarding care for the patients and their caregivers can compromise their quality of life in a detrimental way.
Follow our WhatsApp channel
